Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
Mirion Technologies Inc (MIR)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
09/16/2025: MIR (5-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Outstanding Performance
These Stocks/ETFs, based on Upturn Advisory, have historically outperformed the market, making them a top-tier choice for investors.
Number of Analysts
5 Analysts rated it
Limited analyst coverage, niche firm, research info may be scarce.
1 Year Target Price $23.5
1 Year Target Price $23.5
| 3 | Strong Buy |
| 2 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit 69.13% | Avg. Invested days 37 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  4.0 | Stock Returns Performance  3.0 |
| Profits based on simulation | Last Close 09/16/2025 |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 5.41B USD | Price to earnings Ratio 469.6 | 1Y Target Price 23.5 |
Price to earnings Ratio 469.6 | 1Y Target Price 23.5 | ||
Volume (30-day avg) 5 | Beta 0.82 | 52 Weeks Range 9.58 - 23.94 | Updated Date 09/16/2025 |
52 Weeks Range 9.58 - 23.94 | Updated Date 09/16/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.05 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 1.13% | Operating Margin (TTM) 4.62% |
Management Effectiveness
Return on Assets (TTM) 1.13% | Return on Equity (TTM) 0.7% |
Valuation
Trailing PE 469.6 | Forward PE - | Enterprise Value 5835993812 | Price to Sales(TTM) 6.11 |
Enterprise Value 5835993812 | Price to Sales(TTM) 6.11 | ||
Enterprise Value to Revenue 6.59 | Enterprise Value to EBITDA 28.69 | Shares Outstanding 224440000 | Shares Floating 194846516 |
Shares Outstanding 224440000 | Shares Floating 194846516 | ||
Percent Insiders 4.18 | Percent Institutions 93.19 |
Upturn AI SWOT
Mirion Technologies Inc
Company Overview
History and Background
Mirion Technologies, Inc. was formed in 2006 as a carve-out from Canberra Industries. It has grown through organic growth and acquisitions, becoming a leading provider of radiation detection, measurement, analysis, and monitoring solutions.
Core Business Areas
- Dosimetry Services: Provides comprehensive dosimetry services for monitoring radiation exposure to personnel.
- Radiation Monitoring Systems (RMS): Designs, manufactures, and services radiation monitoring systems for nuclear facilities, hospitals, and other industries.
- Detection & Measurement: Offers a wide range of instruments and solutions for radiation detection and measurement, including portable survey meters, spectrometers, and detectors.
- Health Physics Services: Offers comprehensive solutions for health Physics, including calibration services, consulting, software
Leadership and Structure
Thomas Logan is the current CEO. The company operates with a structure organized around its core business areas.
Top Products and Market Share
Key Offerings
- Instadose Dosimeters: A popular electronic personal dosimeter that provides immediate and accurate radiation dose readings. Competitors include Landauer and Thermo Fisher Scientific. Revenue from Instadose is a significant portion of the dosimetry services segment.
- AccuRad Survey Meters: Portable survey meters used for radiation detection and measurement in various environments. Competitors include Ludlum Measurements and Fluke Biomedical. Accounts for a portion of the Detection & Measurement segment revenue.
- RDS Radiation Monitoring System: Comprehensive radiation monitoring solution installed in nuclear facilities. Competitors include Westinghouse and Rolls-Royce. Significant portion of the RMS segment's revenue comes from RDS.
Market Dynamics
Industry Overview
The radiation detection and measurement market is driven by increasing safety regulations, growing nuclear power generation, and rising healthcare applications of radiation. Growing demand for health physics services is a key trend.
Positioning
Mirion Technologies is a major player in the radiation detection and measurement market, known for its comprehensive product portfolio and strong customer base. They have a competitive advantage through their broad range of products and services.
Total Addressable Market (TAM)
The TAM for the radiation detection and measurement market is estimated to be in the billions of dollars annually. Mirion is well positioned in various parts of this market but does not have 100% of the TAM.
Upturn SWOT Analysis
Strengths
- Comprehensive product portfolio
- Strong brand reputation
- Established customer base
- Recurring revenue from services
Weaknesses
- Dependence on nuclear industry
- Competition from larger players
- Exposure to regulatory changes
Opportunities
- Growth in emerging markets
- Expansion into new applications of radiation detection
- Acquisitions of complementary businesses
Threats
- Decline in nuclear power generation
- Economic downturn
- Technological obsolescence
Competitors and Market Share
Key Competitors
- LAND
- Thermo Fisher Scientific (TMO)
- Fluke Biomedical (part of FTV)
Competitive Landscape
Mirion Technologies has a comprehensive product offering, but faces competition from larger, more diversified companies. Their advantage lies in niche markets and specialized solutions.
Major Acquisitions
Biodex Medical Systems
- Year: 2024
- Acquisition Price (USD millions): 95
- Strategic Rationale: Expands Mirion's presence in the nuclear medicine and healthcare markets.
Growth Trajectory and Initiatives
Historical Growth: Historical growth has been driven by organic expansion and strategic acquisitions.
Future Projections: Future projections depend on market conditions and company initiatives; analyst estimates are unavailable.
Recent Initiatives: Recent initiatives includes investment in technology and product development and market expansion.
Summary
Mirion Technologies is a key player in the radiation detection and measurement market with a strong product portfolio and recurring revenue. They face competition from larger companies and depend on the nuclear industry. Recent acquisitions have positioned them for further growth, but the reliance on nuclear could be a risk.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Website
- Industry Reports
- Financial News Articles
- Public Filings
Disclaimers:
This analysis is based on publicly available information and is intended for informational purposes only. It should not be considered financial advice.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Mirion Technologies Inc
Exchange NYSE | Headquaters Atlanta, GA, United States | ||
IPO Launch date 2020-08-20 | Founder, Medical Group President, CEO & Chairman Mr. Thomas D. Logan | ||
Sector Industrials | Industry Specialty Industrial Machinery | Full time employees 2800 | Website https://www.mirion.com |
Full time employees 2800 | Website https://www.mirion.com | ||
Mirion Technologies, Inc. provides radiation detection, measurement, analysis, and monitoring products and services in North America, Europe, and the Asia Pacific. It operates in two segments, Medical, and Nuclear & Safety. The Medical segment offers radiation oncology quality assurance and dosimetry solutions; patient safety solutions for diagnostic imaging and radiation therapy centers; radiation therapy quality assurance solutions for calibrating and verifying imaging and treatment accuracy; and radionuclide therapy products for nuclear medicine applications, such as product handling, medical imaging furniture, and rehabilitation products. This segment improves the quality and safety of cancer care delivery; and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment focuses on addressing critical radiation safety, measurement, and analysis applications; and provides personal radiation detection, identification equipment, and analysis tools. The company's products and solutions also include radiation measurement and monitoring solutions, reactor instrumentation and control detectors, imaging systems and cameras, and waste management systems; laboratory and scientific analysis systems comprising gamma/alpha spectroscopy, alpha/beta counting, specialty detectors, and spectroscopy software; radiation measurement and health physics instrumentation; and contamination and clearance monitors. It serves hospitals, clinics and urgent care facilities, dental and veterinary offices, radiation treatment facilities, OEMs for radiation therapy, laboratories, military organizations, government agencies, industrial companies, power and utility companies, reactor design firms, and NPPs. The company was formerly known as Global Monitoring Systems, Inc. and changed its name to Mirion Technologies, Inc. in January 2006. Mirion Technologies, Inc. was incorporated in 2005 and is headquartered in Atlanta, Georgia.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.